[3] This extra medication assures that the patient is comfortable at the initiation of the modality and will be able to sustain blood levels sufficient to maintain pain relief.

The form for patient-controlled analgesia (PCA) was updated to offer an alternative for morphine-allergic patients. Nursing education was provided by pharmacists and focused on the rationale for ...

You may be receiving patient-controlled epidural analgesia or PCEA. What this means is that you will be receiving a continuous infusion of the epidural medication and you will also have a control ...

Patient-controlled analgesia (called PCA). You control the administration of the pain medicine by pressing a button to inject medicine at controlled amounts and intervals through an intravenous tube ...

Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.

Therapies provided by the Pain Rehabilitation Program include patient-controlled analgesia (PCA) and nurse- or parent-controlled analgesia for young children and for physically or cognitively impaired ...

Many of our patients will be able to use a method of pain relief called patient-controlled analgesia (PCA). This method allows patients to customize the delivery of their pain medication via ...

Objectives To explore patient experiences, understanding and perceptions of analgesia following major lower limb amputation. Design Qualitative interview study, conducted as part of a randomised ...

Children as young as 7 years old can use this method. Read more about patient-controlled analgesia (PDF). This method gives pain medicine through a tube (catheter) in the space around your child's ...

The project aimed to minimise the risk of medication errors in nurse- or patient-controlled analgesia (N/PCA) for children. Method A system management approach was developed to minimise complex ...

resulted in a reduction of opioid consumption delivered by patient-controlled analgesia (PCA) for acute pain in sickle cell disease. Design A randomised, placebo-controlled, double-blind trial.